EMBIBATINIB

UNII:	4A526T2S3H
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₃H₁₈ClF₄N₅O₃
Preferred Substance Name:	EMBIBATINIB
InChIKey:	MTFOIMMCUOJPHL-GFCCVEGCSA-N
GSRS Full Record:	4A526T2S3H i

2412966-86-8
(R)-N-(4-(Chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzimidazole-5-carboxamide
1H-Benzimidazole-5-carboxamide, N-[4-(chlorodifluoromethoxy)phenyl]-2-(difluoromethyl)-1-[(1R)-2-hydroxy-1-methylethyl]-7-(5-pyrimidinyl)-
Embibatinib
N-[4-(Chlorodifluoromethoxy)phenyl]-2-(difluoromethyl)-1-[(1R)-2-hydroxy-1-methylethyl]-7-(5-pyrimidinyl)-1H-benzimidazole-5-carboxamide
N-[4-[chloro(difluoro)methoxy]phenyl]-2-(difluoromethyl)-1-[(2R)-1-hydroxypropan-2-yl]-7-pyrimidin-5-ylbenzimidazole-5-carboxamide
embibatinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EMBIBATINIB

Synonyms and Mappings

Resources